Back
Surgery Partners Stock Price Chart

Economy going through a "period of transition" - Your portfolio doesn't have to
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
28
SGRY
Surgery Partners
Last Price:
$24.41
Seasonality Move:
0.2%
7 Day Trial
ALL ACCESS PASS
$
7

The Tariff-Proof Asset in Your Pocket
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SGRY is experiencing buying pressure, which is a positive indicator for future bullish movement.
Surgery Partners Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 23.85 | Buy |
20-day SMA: | 24.61 | Sell |
50-day SMA: | 23.43 | Buy |
200-day SMA: | 26.49 | Sell |
8-day EMA: | 23.96 | Buy |
20-day EMA: | 24.21 | Buy |
50-day EMA: | 24.07 | Buy |
200-day EMA: | 26.07 | Sell |
Surgery Partners Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.1 | Sell |
Relative Strength Index (14 RSI): | 53.16 | Buy |
Chaikin Money Flow: | 422504 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (23.93 - 25.69) | Sell |
Bollinger Bands (100): | (20.85 - 27.85) | Buy |
Surgery Partners Technical Analysis
Mar 3 | Mar 4 | Mar 5 | Mar 6 | Mar 7 | Mar 11 | Mar 12 | Mar 13 | Mar 14 | Mar 17 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
03 | 04 | 05 | 06 | 07 | 11 | 12 | 13 | 14 | 17 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Surgery Partners Stock
Is Surgery Partners Stock a Buy?
-
Surgery Partners share price is 24.40 while SGRY 8-day simple moving average is 23.85, which is a Buy signal.
-
The stock price of SGRY is 24.40 while Surgery Partners 20-day SMA is 24.61, which makes it a Sell.
-
Surgery Partners 50-day simple moving average is 23.43 while SGRY share price is 24.40, making it a Buy technically.
-
SGRY stock price is 24.40 and Surgery Partners 200-day simple moving average is 26.49, creating a Sell signal.
SGRY Technical Analysis vs Fundamental Analysis
Sell
28
Surgery Partners (SGRY)
is a Sell
Is Surgery Partners a Buy or a Sell?
-
Surgery Partners stock is rated a SellThe current Surgery Partners [SGRY] share price is $24.40. The Score for SGRY is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
Surgery Partners Stock Info
Market Cap:
3.1B
Price in USD:
24.40
Share Volume:
639.5K
Surgery Partners 52-Week Range
52-Week High:
33.97
52-Week Low:
19.50
Sell
28
Surgery Partners (SGRY)
is a Sell
Surgery Partners Share Price Forecast
-
What is the Surgery Partners stock price today?The Surgery Partners stock price is 24.40 USD today.
-
Will SGRY stock go up or go down?Surgery Partners> share price is forecast to RISE/FALL based on technical indicators
-
Is Surgery Partners overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Surgery Partners is overvalued.
Is Surgery Partners Stock a Buy?
-
Surgery Partners share price is 24.40 while SGRY 8-day exponential moving average is 23.96, which is a Buy signal.
-
The stock price of SGRY is 24.40 while Surgery Partners 20-day EMA is 24.21, which makes it a Buy.
-
Surgery Partners 50-day exponential moving average is 24.07 while SGRY share price is 24.40, making it a Buy technically.
-
SGRY stock price is 24.40 and Surgery Partners 200-day simple moving average is 26.07, creating a Sell signal.
Fundamental Analysis of Surgery Partners
Is Surgery Partners a good investment?
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.14 per share, an increase this year of $0.15 per share, and an increase next year of $0.34 per share.
Technical Analysis of Surgery Partners
Should I short Surgery Partners stock?
-
SGRY Moving Average Covergence Divergence (MACD) indicator is -0.1, suggesting Surgery Partners is a Sell
-
Surgery Partners Relative Strength Index (RSI) is 53.16, which suggest Surgery Partners is overbought
-
The Bollinger Bands (25) for Surgery Partners is (23.93 - 25.69), which suggest Surgery Partners is a Buy
-
The Bollinger Bands (100) for Surgery Partners is (20.85 - 27.85), which suggest Surgery Partners is a Buy
* Surgery Partners stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.